<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34609007</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0096</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of clinical ultrasound : JCU</Title><ISOAbbreviation>J Clin Ultrasound</ISOAbbreviation></Journal><ArticleTitle>Diaphragmatic ultrasound: Prospects as a tool to assess respiratory muscle involvement in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>131</StartPage><EndPage>135</EndPage><MedlinePgn>131-135</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jcu.23069</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ultrasonography (USG) of the diaphragm is a promising alternative to pulmonary function tests (PFT) for assessing respiratory function in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied 33 patients fulfilling Awaji criteria (definite&#xa0;=&#xa0;14; probable&#xa0;=&#xa0;12; possible&#xa0;=&#xa0;7) and 33 age and gender-matched controls. Diaphragm thickness was measured using USG at the end of expiration (DTex) and end of inspiration (DTin). The thickness ratio (TR) was calculated as DTin/DTex. The mean age at onset and duration were 49.73&#x2009;&#xb1;&#x2009;12.7&#x2009;years and 13.57&#x2009;&#xb1;&#x2009;9.7&#xa0;months, respectively. Men&#xa0;=&#xa0;25 (75.8%); Limb onset ALS/MND&#xa0;=&#xa0;24 patients (72.7%); bulbar onset&#xa0;=&#xa0;9 (27.3%).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared to controls, ALS/MND patients had reduced mean DTex (2.22&#x2009;&#xb1;&#x2009;0.29&#x2009;mm vs. 2.02&#x2009;&#xb1;&#x2009;0.32&#x2009;mm, p&#xa0;=&#xa0;.012) and DTin (4.0&#x2009;&#xb1;&#x2009;0.71&#x2009;mm vs. 3.41&#x2009;&#xb1;&#x2009;0.38&#x2009;mm, p&#x2009;&lt;&#x2009;.001). PFTs done in 31 patients showed restrictive abnormality in 80.6%. Significant positive correlation was seen between percentage of predicted forced vital capacity (FVC%) and DTin (p&#xa0;=&#xa0;.009) and TR (p&#xa0;=&#xa0;.037) but not with DTex (p&#xa0;=&#xa0;.852). No significant correlation was seen between diaphragmatic thickness and other PFT parameters or ALSFRS scores.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The diaphragmatic thickness showed a significant decrease in ALS/MND as compared to controls. End-inspiratory diaphragmatic thickness and TR correlated well with %FVC. Thus, diaphragmatic USG could be a potential alternative to PFTs in assessing respiratory function in ALS/MND patients having the advantage of less patient participation and ease of performing in late stages of ALS/MND.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rajula</LastName><ForeName>Rahul Reddy</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saini</LastName><ForeName>Jitender</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unnikrishnan</LastName><ForeName>Gopikrishnan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vengalil</LastName><ForeName>Seena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nashi</LastName><ForeName>Saraswati</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bardhan</LastName><ForeName>Mainak</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4106-409X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huddar</LastName><ForeName>Akshata</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chawla</LastName><ForeName>Tanushree</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sindhu</LastName><ForeName>Dodmalur Mallikarjuna</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganaraja</LastName><ForeName>Valakunja Harikrishna</ForeName><Initials>VH</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polavarapu</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preethish-Kumar</LastName><ForeName>Veeramani</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kandavel</LastName><ForeName>Thennarasu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyaprabha</LastName><ForeName>Talakad N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalini</LastName><ForeName>Atchayaram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Institute of Mental Health And Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Ultrasound</MedlineTA><NlmUniqueID>0401663</NlmUniqueID><ISSNLinking>0091-2751</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003964" MajorTopicYN="N">Diaphragm</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014797" MajorTopicYN="N">Vital Capacity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">diaphragm</Keyword><Keyword MajorTopicYN="N">pulmonary function tests</Keyword><Keyword MajorTopicYN="N">ultrasonography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>8</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34609007</ArticleId><ArticleId IdType="doi">10.1002/jcu.23069</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006 Feb;5(2):140-147.</Citation></Reference><Reference><Citation>Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017 Oct 6;10:CD004427.</Citation></Reference><Reference><Citation>Peseschkian T, Cordts I, G&#xfc;nther R, et al. A nation-wide, multi-center study on the quality of life of ALS patients in Germany. Brain Sci. 2021;11(3):372.</Citation></Reference><Reference><Citation>Hiwatani Y, Sakata M, Miwa H. Ultrasonography of the diaphragm in amyotrophic lateral sclerosis: clinical significance in assessment of respiratory functions. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(2):127-131.</Citation></Reference><Reference><Citation>Pinto S, Alves P, Pimentel B, Swash M, de Carvalho M. Ultrasound for assessment of diaphragm in ALS. Clin Neurophysiol. 2016;127(1):892-897.</Citation></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497-503.</Citation></Reference><Reference><Citation>Ueki J, De Bruin PF, Pride NB. In vivo assessment of diaphragm contraction by ultrasound in normal subjects. Thorax. 1995;50(11):1157-1161.</Citation></Reference><Reference><Citation>IBM Corp. IBM SPSS Statistics for Windows, Version 26.0. IBM Corp.; 2019.</Citation></Reference><Reference><Citation>Sartucci F, Pelagatti A, Santin M, Bocci T, Dolciotti C, Bongioanni P. Diaphragm ultrasonography in amyotrophic lateral sclerosis: a diagnostic tool to assess ventilatory dysfunction and disease severity. Neurol Sci. 2019;40(10):2065-2071.</Citation></Reference><Reference><Citation>Aliberti S, Messinesi G, Gramegna A, Tremolizzo L, Susani E, Pesci A. Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis. Vol. 14, amyotrophic lateral sclerosis and frontotemporal degeneration. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(2):154-156.</Citation></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review). Neurology. 2009;73(15):1218-1226.</Citation></Reference><Reference><Citation>EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012 Mar;19(3):360-375.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>